Edition:
India

XBiotech Inc (XBIT.OQ)

XBIT.OQ on NASDAQ Stock Exchange Global Select Market

4.17USD
15 Dec 2017
Change (% chg)

$-0.30 (-6.71%)
Prev Close
$4.47
Open
$4.48
Day's High
$4.49
Day's Low
$4.05
Volume
629,429
Avg. Vol
38,491
52-wk High
$20.18
52-wk Low
$2.80

Latest Key Developments (Source: Significant Developments)

XBiotech says announces successful completion of EMA GMP inspection
Wednesday, 12 Oct 2016 

XBiotech Inc : XBiotech announces successful completion of EMA GMP inspection . Says findings allow french agency to recommend to EMA xBiotech's current facility for commercial manufacture of xilonix .XBiotech inc - company expects EMA decision on marketing application as early as end of 2016.  Full Article

Xbiotech files for stock shelf of upto 7 mln shares
Saturday, 20 Aug 2016 

Xbiotech Inc :Files for stock shelf of up to 7 million common shares - SEC filing.  Full Article

XBiotech signs agreement with Megapharm to market xilonix in israel
Tuesday, 28 Jun 2016 

XBiotech Inc : XBiotech signs agreement with Megapharm to market xilonix in Israel . XBiotech Inc says under terms of agreement, Megapharm will pay XBiotech an undisclosed upfront fee .In addition, upon approval, Megapharm will purchase xilonix from XBiotech at a supply price that is based on a percentage of net sales of product.  Full Article

XBiotech Inc appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer
Tuesday, 3 May 2016 

XBiotech Inc:Says appointment of Scott Whitehurst as Chief Financial Officer.  Full Article

BRIEF-XBIOTECH ‍ENROLLS FIRST PATIENT IN STUDY EVALUATING MABP1 IN WITH ONIVYDE

* ‍ENROLS FIRST PATIENT IN STUDY EVALUATING MABP1 IN COMBINATION WITH ONIVYDE & 5-FLUOROURACIL/FOLINIC ACID FOR TREATMENT OF PANCREATIC CANCER​ Source text for Eikon: Further company coverage: